Impact of COVID-19 on breast cancer screening in the Brazilian Unified Health System (SUS)
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2023.201567Keywords:
Breast neoplasms, Women, Mammography, COVID-19, Medical oncologyAbstract
Objectives: investigating the impact of the pandemic on breast cancer screening in the Unified Health System, in addition to comparing the data obtained from other countries. Methods: a quantitative cross-sectional observational study was carried out, with references from the Cancer Information System - SISCAN on the number of mammograms performed from 2014 to 2022 by women in Brazil. Results: data regarding mammography in the high-risk population showed a drop of 38,39% from 2019 to 2020. While in screening mammography, the decline was slightly more significant, at 39.18% in the same period. Regarding diagnostic mammography, the reduction was 33.15%, and in target population mammography, the peak was in 2019 with 2.721.075. On the other hand, the performance of mammography in patients already treated had a smaller decrease of 9.35%. Conclusions: there was a significant reduction in the number of mammograms performed in 2019 and 2020, which might lead to a late diagnosis of the disease and a worse prognosis.
Downloads
References
OPAS. Histórico da pandemia de covid-19 [internet]. Brasília: OPAS; 2020. [citado em 2021 maio 8]. Disponível em: https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19
UNA-SUS. Coronavírus: Brasil confirma primeiro caso da doença [internet]. Brasília: UNA-SUS; 2020. [atualizado em 2020 fev. 27, citado em 2021 maio 08]. Disponível em: https://www.unasus.gov.br/noticia/coronavirus-brasil-confirma-primeiro-caso-da-doenca
Barcelos R. Número de mortes por covid-19 no Brasil em 2021 já supera todo ano de 2020 [internet]. CNN Brasil. 2021 abr. 25 [citado em 2021 maio 08]. Disponível em: https://www.cnnbrasil.com.br/saude/2021/04/25/numero-de-mortes-por-covid-19-no-brasil-em-2021-ja-supera-todo-ano-de-2020
OPAS. Folha informativa sobre COVID-19 [internet]. Brasília: OPAS; 2020. [citado em 2021 maio 8]. Disponível em: https://www.paho.org/pt/covid19
Galindo RJSC, Andrade LB, Sena GR, Nogueira LRM, Lima TPF, Lima JTO, et al. Mulheres com cancer e COVID-19: uma análise da letalidade e aspectos clínicos em Pernambuco. Rev. Bras. Saúde Matern. Infant. 2021 Fev;21(1):157-65. doi: 10.1590/1806-9304202100S100008
Aquino EML, Silveira IH, Pescarini JM, Aquino R, Souza-Filho JA, Rocha AS, et al. Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil. Ciênc. saúde coletiva. 2020 Jun;25(1):2423-46. doi: 10.1590/1413-81232020256.1.10502020
INCA. Nota Técnica – DIDEPRE/CONPREV/INCA Rastreamento de câncer durante a pandemia de COVID-19 - 09/07/2020 [internet]. Rio de Janeiro: INCA; 2020. [citado em 2021 maio 8]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//nota-tecnica-rastreamento-covid-didepre-09-jul-2020.pdf
WHO. COVID-19 significantly impacts health services for noncommunicable diseases [internet]. World Health Organization (WHO); 2020. [atualizado em 2020 jun. 1; citado em 2021 maio 8]. Disponível em: https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases
INCA. A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação [internet]. Rio de Janeiro: INCA; 2019 [citado em 2021 maio 8]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/a_situacao_ca_mama_brasil_2019.pdf
INCA. Câncer de mama [internet]. São Paulo: INCA; 2021 [atualizado em 2021 mar. 4; citado em 2021 maio 8]. Disponível em: https://www.inca.gov.br/tipos-de-cancer/cancer-de-mama
Filipe MD, Deukeren DV, Kip M, Doeksen A, Pronk A, Verheijen PM, et al. Efecct of the COVID-19 pandemic on surgical breast cancer care in the Netherlands: a multicenter retrospective cohort study. Clinical breast cancer. 2020 Dez;20(6):454-61. doi: 10.1016/j.clbc.2020.08.002
Gathani T, Clayton Gill, Maclnnes E, Horgan K. The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020. BJC. 2020 Nov;124:710–712. doi: 10.1038/s41416-020-01182-z
Li J, Wang H, Geng C, Liu Z, Lin Y, Nie J, et al. Suboptimal declines and declays in early breast cancer treatment after COVID-19 quarantine restrictions in China: a national survey of 8397 patients in the first quarter of 2020. EClinicalMedicine. 2020 Set;26:100503. doi: 10.106/j.eclinm.2020.100503
Smetherman DH, MD, MPH, MBA, FACR. Breast Cancer Screening and the COVID-19 Pandemic. Journal of breast imaging. 2020 Dez;3(1):3-11. doi: 10.1093/jbi/wbaa106
Humerez DC, Ohl RIB, Silva MCN. Saúde mental dos profissionais de enfermagem do brasil no contexto da pandemia covid-19: ação do conselho federal de enfermagem. Cogitare enferm. [internet]. Mai 2020 [citado 2 maio 2022];25. Disponível em: https://doi.org/10.5380/ce.v25i0.74115
CFM. Para enfrentar a covid-19, o Brasil conta com 422 mil médicos com menos de 60 anos em atividade [internet]. Brasília: CFM; 2020 [citado em 2022 maio 2]. Disponível em: https://portal.cfm.org.br/noticias/para-enfrentar-a-covid-19-o-brasil-conta-com-422-mil-medicos-com-menos-de-60-anos-em-atividade/.
CFM - Memorial aos médicos que se foram durante o combate à COVID-19 [internet]. Brasília: CFM; 2021 [citado em 2022 maio 2]. Disponível em: https://memorial.cfm.org.br/.
Nações Unidas Brasil. Até 180 mil profissionais de saúde morreram de COVID-19, informa OMS [internet]; 2021 [citado em 2022 maio 2]. Disponível em: https://brasil.un.org/pt-br/152760-ate-180-mil-profissionais-de-saude-morreram-de-covid-19-informa-oms#:~:text=19,%20informa%20OMS-,Até%20180%20mil%20profissionais%20de,de%20COVID-19,%20informa%20OMS
OPAS. Se tenho câncer, o que preciso saber sobre a COVID-19 [internet]. Brasília: OPAS; 2020. [citado em 2022 maio 2]. Disponível em: https://iris.paho.org/bitstream/handle/10665.2/52785/OPASBRANMHNVCOVID-19200013_por.pdf?sequence=1&isAllowed=y
Almeida AL, Santo TME, Mello MSS, Cedro AV, Lopes NL, Ribeiro APMR, et al. Repercussões da Pandemia de COVID-19 na Prática Assistencial de um Hospital Terciário. Arq Bras de Cardiol. 2020 Set:115(5):862-70. doi: 10.36660/abc.20200436
Barros LAR, Filho MAFN, Alves RB, Rebouças CV, Rodrigues CM, Viu MM, et al. Alta mortalidade entre pacientes com câncer e infecção por COVID-19: a experiência de um centro oncológico brasileiro. Einstein. 2021 Out:19:eAO6254. doi: 10.31744/einstein_journal/2021AO6254
De Vincentiis L, Carr RA, Mariani MP, Ferrara G. Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology. J Clin Patol. 2021 Jun;74:187–189. doi: 10.1136/jclinpath-2020-206833
Vrdoljak E, Balja MP, Marusic Z, Avirovic M, Blazicevic V, Tomasovic C, et al. Covid-19 pandemic effects on breast cancer diagnosis in Croatia: a population- and registry-based study. The oncologist. 2021 Abr;26:1–5. doi: 10.1002/onco.13791
Tsai HY, Chang YL, Shen CT, Chung WS, Tsai HJ, Chen FM. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan. Breast. 2020 Set;54:52-55. doi: 10.1016/j.breast.2020.08.014
Sutherland K, Chessman J, Zhao J, Sara G, Shetty A, Smith S, et al. Impact of COVID-19 on healthcare activity in NSW, Australia. Public Health Res Pract. 2020 Dez;30(4):e3042030. doi: 10.17061/phrp3042030
Toyoda Y, Katanoda K, Ishii K, Yamamoto H, Tabuchi T. Negative impact of the COVID 19 state of emergency on breast cancer screening participation in Japan. Breast Cancer. 2021 Jul;28(6):1340-45. doi: 10.1007/s12282-021-01272-7
Linck PA, Garnier C, Depetiteville MP, MacGrogan G, Mathoulin-Pélissier S, Quénel-Tueux N, et al. Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre. Eur Radiol. 2021 Out;32(3):1644-51. doi: 10.1007/s00330-021-08264-3
Al-Kuwari MG, Abdulmalik MA, Al-Mudahka HR, Bakri AH, Al-Baker WA, Abushaikha SS, et al. The impact of COVID-19 pandemic on the preventive services in Qatar. J Public Health Res. 2021 Jan;10(1):1910. doi: 10.4081/jphr.2021.1910
Peacock HM, Tambuyzer T, Verdoodt F, Calay F, Poirel HA, De Schutter H, et al. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. ESMO open. 2021 Ago; 6(4):100197. doi: 10.1016/j.esmoop.2021.100197
Kaltofen T, Hagemann F, Harbeck N, Wuerstlein R, Kost BP, Burges A, et al. Changes in gynecologic and breast cancer diagnoses during the frst wave of the COVID 19 pandemic: analysis from a tertiary academic gyneco oncological center in Germany. Arch Gynecol Obstet. 2021 Set;305(3):713-18. doi: 10.1007/s00404-021-06211-7
Wyngaard TV, Cairncross L, Maswime S, Roodt L, Malherbe F. Impact of COVID-19 on breast cancer diagnostic and surgical services at a South African academic hospital. S. Afr J Surg. 2022 Jun;60(2):119-123. doi: 10.17159/2078-5151/SAJS3750
Sistema de Informação do Câncer – SISCAN (colo do útero e mama). DATASUS [Internet]. [citado em 2022 agosto 24]. Disponível em: https://datasus.saude.gov.br/acesso-a-informacao/sistema-de-informacao-do-cancer-siscan-colo-do-utero-e-mama/
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Felipe Augusto Rodrigues Murat, Natalia Martins Faria, Ane Caroline Tedeschi Gonçalves, Fernanda Pataro Marsola Razera, Ana Paula Ribeiro Razera
This work is licensed under a Creative Commons Attribution 4.0 International License.
